Christopher R. Fenimore, VP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 13,551 shares at $641.58 ($8.8M) on 2020-07-21, disclosed to the SEC on 2020-07-22.
Open-market sale of $8.8M REGN by VP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $655.57 | 6,291 | $4.1M | 46.9% |
| 2 | $636.56 | 216 | $137K | 1.6% |
| 3 | $636.56 | 216 | $137K | 1.6% |
| 4 | $637.88 | 154 | $98K | 1.1% |
| 5 | $637.88 | 154 | $98K | 1.1% |
| 6 | $638.51 | 306 |
| $195K |
| 2.2% |
| 7 | $638.51 | 306 | $195K | 2.2% |
| 8 | $639.64 | 75 | $48K | 0.5% |
| 9 | $640.61 | 113 | $72K | 0.8% |
| 10 | $640.61 | 113 | $72K | 0.8% |
| 11 | $641.58 | 855 | $549K | 6.2% |
| 12 | $641.58 | 855 | $549K | 6.2% |
| 13 | $642.39 | 676 | $434K | 4.9% |
| 14 | $642.39 | 676 | $434K | 4.9% |
| 15 | $643.49 | 691 | $445K | 5.1% |
| 16 | $643.49 | 691 | $445K | 5.1% |
| 17 | $644.57 | 303 | $195K | 2.2% |
| 18 | $644.57 | 303 | $195K | 2.2% |
| 19 | $645.33 | 72 | $46K | 0.5% |
| 20 | $646.82 | 155 | $100K | 1.1% |
| 21 | $646.82 | 155 | $100K | 1.1% |
| 22 | $647.79 | 82 | $53K | 0.6% |
| 23 | $647.79 | 82 | $53K | 0.6% |
| 24 | $658.00 | 11 | $7K | 0.1% |
| Total | $648.30 avg | 13,551 | $8.8M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |